Dr. Reddy’s Laboratories · $2.99 Billion · Hyderabad · Founded 1984
Anji Reddy built India’s first Paragraph IV patent challenge and proved Indian pharma could compete at the highest level of the American generic drug market. NYSE-listed since 2001, with 394 FDA drug approvals across 13 manufacturing sites and 24,800 employees.
Lupin Limited · $2.70 Billion · Mumbai · Founded 1968
Desh Bandhu Gupta started with tuberculosis drugs in 1968 and built India’s third largest pharmaceutical company in the US by prescriptions. Lupin holds 308 FDA approvals across 14 plants, with a growing complex generics and specialty pipeline and 24,000 employees.
Alkem Laboratories · $1.63 Billion · Mumbai · Founded 1973
Anti-infectives and gastrointestinal care since 1973. Alkem has quietly built India’s leading position in acute therapy, plus a growing US generics business with 164 FDA approvals, 4 FDA-registered plants, and 19,000 employees.
Mankind Pharma · $1.47 Billion · New Delhi · Founded 1995
The deepest rural distribution network in Indian pharma. Mankind reaches towns and villages that larger companies overlook, serving patients who would otherwise go without. IPO’d in 2023 with 65 FDA approvals and 28,000 employees.
Macleods Pharmaceuticals · $1.17 Billion · Mumbai · Founded 1989 · Private
Essential anti-TB and antimalarial drugs supplied to Africa and Asia. Macleods is one of the largest suppliers to international health programmes, with 177 FDA approvals, WHO prequalification, and 15,000 employees working to get medicines where they are needed most.
IPCA Laboratories · $1.07 Billion · Mumbai · Founded 1949
Seventy-five years of chemistry expertise, from APIs to finished formulations. IPCA holds a dominant position in tropical disease medicines with 33 FDA approvals across 7 FDA-registered plants and 17,000 employees.
Alembic Pharmaceuticals · $904 Million · Vadodara · Founded 1907
One of India’s oldest pharmaceutical companies. Their penicillin plant was inaugurated by Prime Minister Shastri in 1961. Today, Alembic holds 342 FDA approvals — the sixth highest among all Indian companies — across 9 manufacturing plants and 8 FDA-registered facilities.
Abbott India · $750 Million · Mumbai · Incorporated 1944
Incorporated in 1944 as Boots Pure Drug Company, Abbott India is one of the oldest multinational pharmaceutical operations in the country. A market leader across pharmaceuticals, nutrition, diagnostics, and medical devices, with over 400 trusted brands, 3 plants, and 7,600 employees.
Ajanta Pharma · $560 Million · Mumbai · Founded 1973
Branded generics in Africa, Asia, and beyond. Ajanta built a profitable niche serving markets that larger companies often ignore, with 79 FDA approvals, 2 FDA-registered plants, and 9,600 employees.
Panacea Biotec · $31 Million · New Delhi · Founded 1984
Small in revenue, enormous in impact. Panacea Biotec has supplied over ten billion polio immunisations worldwide and holds WHO prequalification for multiple vaccines. Founded by Soshil Kumar Jain in 1984, it is one of India’s few WHO-prequalified vaccine manufacturers with 830 employees.
Zydus Lifesciences · $2.77 Billion · Ahmedabad · Founded 1952
Developer of the world’s first dual PPAR agonist and India’s first COVID vaccine. From a family generics business to a research-driven company with 481 FDA approvals, its own new chemical entities, and 27,000 employees.
Intas Pharmaceuticals · $2.50 Billion · Ahmedabad · Founded 1977 · Private
Hasmukh Chudgar started Intas from a pharmacy in Ahmedabad in 1977. Today his company operates 22 manufacturing plants across four countries and supplies medicines to 85 markets through its Accord Healthcare subsidiary, employing 20,000 people.
Glenmark Pharmaceuticals · $1.60 Billion · Mumbai · Founded 1977
Glenmark bet early on proprietary drug discovery in dermatology, respiratory, and oncology. The gamble took the company across 80 countries with 216 FDA approvals, 7 FDA-registered plants, and 15,800 employees.
Torrent Pharmaceuticals · $1.38 Billion · Ahmedabad · Founded 1959
The branded generics specialist with leading positions in Brazil and Germany. Torrent built a cardiovascular and CNS franchise across international markets with 135 FDA approvals, 5 FDA plants, and 17,300 employees.
Piramal Pharma · $1.07 Billion · Mumbai · Founded 1988
Ajay Piramal entered healthcare in 1988 and built one of the few Indian companies with a global CDMO network spanning North America, Europe, and India. Seventeen facilities, 6,700 employees, and 11 FDA-registered plants.
Emcure Pharmaceuticals · $948 Million · Pune · Founded 1981
Science-led, patient-first. Emcure built its reputation in women’s health and complex formulations before going public in July 2024. Fourteen FDA approvals and 4 FDA-registered plants serve markets across Europe and North America.
Micro Labs · $900 Million · Bengaluru · Founded 1973 · Private
Home of Dolo-650, the paracetamol brand that became a household name during COVID. Behind that single brand, Micro Labs has quietly built a formidable generics business with 123 FDA approvals, 5 FDA plants, and 14,000 employees.
USV Private Limited · $610 Million · Mumbai · Founded 1961 · Private
Number one in India’s oral anti-diabetic market by prescriptions and value. Founded by Dr. Vithal Balkrishna Gandhi — a freedom fighter and Columbia University alumnus — through a technology transfer deal with USV&P Inc. Seven manufacturing plants, all FDA-accredited, and 5,800 employees.
Natco Pharma · $534 Million · Hyderabad · Founded 1981
Natco built its reputation on Paragraph IV patent challenges and oncology access, making cancer drugs affordable for millions of patients who could not otherwise afford treatment. Ninety-one FDA approvals and 4 plants — punching well above its weight.
Cadila Pharmaceuticals · $455 Million · Ahmedabad · Founded 1952 · Private
Founded by Indravadan Modi, known as the “Medicine Man of India.” Modi championed the Indian Patents Act of 1970 and built a company on the vision of making modern medicine affordable and accessible to the last person in society. Present across 100 countries. (Separate from Zydus Lifesciences.)